DIHEXA
US$ 24.46
iv glutathione connecticut Therapy in IV Therapy in Connecticut |
Description
10.1001/jamaneurol.2017.0655 JAMA Neurol
Schulte ML, Fu A, Zhao P, Li J, Geng L, Smith ST, Kondo J, Coffey RJ
This medicine is typically administered via subcutaneous or intramuscular injection
S.SmithS
In the FY 2019 IPPS/LTCH PPS final rule (83 FR 41559 and 41560), we removed the MSPB Hospital measure from the Hospital IQR Program beginning with the FY 2022 payment determination under measure removal factor 8, the costs associated with a measure outweigh the benefit of its continued use in the program
